◆ Smart and progressive, steady behavior for far-reaching

◆ Technology-based, innovation first
 

Committed to the grand blueprint of human high-end pharmaceutical production enterprise, focusing on R&D and continuous innovation, we have prompted us to explore and solve the core problems of survival and development using technologies such as microchannels, biomedicine, and enzymatic methods.

Pay more attention to the capital operation of the enterprise, and strive to create the maximum return on investment for shareholders.

Continuously improve the management system, constantly create new economic growth points, and constantly develop high-tech products, so that our enterprise can take off again.